Gilead PrEP lenacapavir succeeds in Phase 3 trial

Health | 344 hits | Jun 24 6:08 am | Posted by: DrCaleb

Gilead's experimental twice-yearly medicine to prevent HIV was 100% effective in a late-stage trial, the company said Thursday.

Comments

You need to be a member of CKA and be logged into the site, to comment on news.

Share

All logos and trademarks in this site are property of their respective owner.
The comments are property of their posters, all the rest © 2024 by Canadaka.net